Drug intelligence / Profile preview

butaphosphan + cyanocobalamin (Navana Pharmaceuticals)

Development stage
Unknown
Lead developer
Navana Pharmaceuticals
Modality
Small Molecules
Administration
Intramuscular, Intravenous, Oral, Subcutaneous
01

Overview

Navasol (also known as Navasol Vet) is a veterinary metabolic stimulant and tonic developed by Navana Pharmaceuticals. It is a co-formulated injectable solution containing butaphosphan, an organic phosphorus compound, and cyanocobalamin (Vitamin B12). Butaphosphan acts as an anabolic agent and metabolic stimulant that enhances ATP cycling, supports liver function, and promotes gluconeogenesis. Cyanocobalamin serves as an essential cofactor for methionine synthase and methylmalonyl-CoA mutase, which are critical for protein, carbohydrate, and lipid metabolism, as well as erythropoiesis. Navasol is indicated for livestock and poultry to treat malnutrition, poor growth, debility, convalescence, and metabolic disorders, and to boost resistance under stress conditions.

Brand names
Navasol
Other names
butaphosphan and cyanocobalaminbutaphosphan and vitamin B12butaphosphan/cyanocobalaminbutaphosphan/vitamin B12
02

Targets

MTR (Methionine synthase)MMUT (Methylmalonyl-coenzyme A mutase)

Beyond the preview

Go deeper on butaphosphan + cyanocobalamin (Navana Pharmaceuticals).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on butaphosphan + cyanocobalamin (Navana Pharmaceuticals).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call